Expanded metabolic-care platform with NAD+ and sermorelin offerings

Polly review

Polly is a prescription-access platform to compare for a defined need, rather than a complete preventive-health program. I would establish the actual intervention, clinical team and full paid term first. A wider menu, lower prepaid equivalent or hormonal mechanism does not establish improved healthspan from a combination of prescriptions.

A useful next step?

Consider the purpose, the care relationship and the full commitment.

Visit PollyOfficial provider website. No affiliate relationship is currently listed.

A reason to consider it

Someone who can identify a useful clinical decision and coordinate the selected treatment with existing care.

  • The official rebrand and current product expansion are explained.
  • Product prices and some actual upfront totals are public.
  • Clinical and pharmacy work is distinguished from platform administration.

What deserves scrutiny

A reader seeking a general longevity result from several prescription options or a prepaid bundle.

  • NAD+ and sermorelin help pages describe adjunct use with GLP-1 care.
  • Each product needs its own evidence and appropriate monitoring.
  • Prepaid supply and conditional early-exit adjustments limit flexibility.
In this review

An expanded identity still needs a defined purpose

Polly’s official rebrand says it continues Piper’s service while expanding its wellness scope. The current catalogue actually names compounded semaglutide and tirzepatide, NAD+ and sermorelin. That establishes product availability to investigate, not that several prescriptions belong in one preventive plan. [1] [2]

The NAD+ and sermorelin help pages describe use alongside GLP-1 care. Confirm access eligibility and the complete selected arrangement; the descriptions do not establish a universal standalone or mandatory-base-plan offer. A different prescription should not be started merely to obtain an add-on. [17] [19]

Identify the actual clinical relationship

Polly provides access and administrative support while independent professionals provide medical and pharmacy services. The home page names possible 503A partners, but the actual prescriber, dispenser and formulation depend on the selected care arrangement. [2] [3]

Ask who interprets concerns, what monitoring is included and what would prompt reconsidering treatment. Portal access and delivery updates are useful services, but do not constitute comprehensive preventive care or prove that multiple prescriptions improve a person’s overall health.

Keep every paid term attached to its product

Monthly semaglutide and tirzepatide are listed at $179 and $279, while the latter’s six-month $199 equivalent requires $1,194 upfront. NAD+ injection has a $199 monthly or $549 three-month upfront option; sermorelin has $229 or $537. These are separate purchases, not one health-program price. [11] [12] [16] [18]

Nasal NAD+ is separately priced, and longer supplies can arrive together. Confirm the actual route, quantity, usable period, any required base purchase and additional assessment before estimating a complete commitment. A discounted equivalent should not conceal how much cash is due now. [16]

Match the outcome to the actual preparation

The NAD+ FAQ connects a coenzyme and delivery routes with energy and focus; the sermorelin FAQ connects hormonal signaling with sleep and recovery. Those explanations do not establish improved function, fewer clinical events or longer healthy life from the selected preparations or their combination. [17] [19]

The GLP-1 articles acknowledge the compounds are not FDA-approved and may have different added ingredients. FDA recommends compounded GLP-1 use for needs an approved drug cannot meet. Branded-product outcomes and pharmacy credentials cannot supply finished-product evidence for a different intervention. [10] [13] [14] [15]

Treat cancellation and a refund as separate actions

The formal policy generally allows an order refund before pharmacy submission and excludes it after transmission. Plan cancellation stops future renewal after confirmation; ordinary unused time is not prorated. Specific ineligibility, verified billing errors and damaged-delivery exceptions are narrower than a result-based guarantee. [4]

Later help articles describe discretionary adjustments for unused supply and loss of a multi-month discount on early exit. Resolve the selected agreement before prepaying rather than assume a first-month trial or a guaranteed unused balance. Card authorization before approval is also different from a refund after prescribed treatment. [6] [7] [8]

Compare a useful addition to existing care

The general refill guidance describes processing around every 25 days. The shipping policy separates approval, preparation and expedited transit; an overnight carrier service is not immediate access to a clinician or a guarantee of next-day arrival after ordering. [5] [8]

I would compare Polly after identifying the clinical question and the actual service that helps address it. A broader wellness label is less persuasive than a coherent purpose, useful follow-up and a complete selected bill. Additional prescriptions should earn their place individually, rather than turn uncertainty into a longevity promise.

Understanding the cost

Semaglutide $179 monthly and tirzepatide $279; longer terms are prepaid, including explicit six-month tirzepatide total $1,194. NAD+ injection $199 monthly or $549 upfront for three months, nasal spray $199 monthly. Sermorelin $229 monthly or $537 upfront for three months. Adjunct eligibility, any base-plan requirement and the complete selected care total need confirmation. [7] [11] [12] [16] [18]

Build your cost estimate

Sources

  1. Polly: official Piper rebrand and account continuity
  2. Polly: current treatment catalogue and pharmacy relationships
  3. Polly: April 29, 2026 clinical, subscription and payment terms
  4. Polly: cancellation, pharmacy-submission cutoff and refund exceptions
  5. Polly: pharmacy preparation, carrier service and shipping concerns
  6. Polly: card authorization and payment after approval
  7. Polly: upfront multi-month billing and discount adjustments
  8. Polly: pausing, cancellation, reviewed refunds and auto-refill cycle
  9. Polly: included care, supplies and payment-method limits
  10. FDA: compounded medicines and premarket-review limits
  11. Polly: semaglutide monthly and multi-month equivalents
  12. Polly: tirzepatide rates and six-month upfront total
  13. Polly: semaglutide formulation, supplied items and compounding status
  14. Polly: tirzepatide formulation, supplied items and compounding status
  15. FDA: concerns with unapproved GLP-1 medicines
  16. Polly: NAD+ injection and nasal spray prices
  17. Polly: NAD+ routes and adjunct-treatment description
  18. Polly: sermorelin monthly and upfront three-month charges
  19. Polly: sermorelin mechanism and adjunct-treatment description

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.